High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Clinically Localized Prostate Cancer: Treatment Evolution and Mature Results-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Clinically Localized Prostate Cancer: Treatment Evolution and Mature Results

Published:2013-03 Issue:3 Volume:85 Page:672-678
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Zamboglou Nikolaos,Tselis Nikolaos,Baltas Dimos,Buhleier Thomas,Martin Thomas,Milickovic Natasa,Papaioannou Sokratis,Ackermann Hanns,Tunn Ulf W.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference25 articles.

1. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer;Potters;J Urol,2005

2. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation;Zelefsky;Int J Radiat Oncol Biol Phys,2007

3. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer;Kuban;Int J Radiat Oncol Biol Phys,2008

4. Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer;Galalae;Int J Radiat Oncol Biol Phys,2004

5. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era;D'Amico;Cancer,2002

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate high dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy: A 9-year update;Radiotherapy and Oncology;2024-09

2. High-dose-rate Brachytherapy Monotherapy in Patients With Localised Prostate Cancer: Dose Modelling and Optimisation Using Computer Algorithms;Clinical Oncology;2024-06

3. AAPM Task Group Report 267: A joint AAPM GEC‐ESTRO report on biophysical models and tools for the planning and evaluation of brachytherapy;Medical Physics;2024-05-09

4. 21 Gy single fraction prostate HDR brachytherapy: 5-year results of a single institution prospective pilot study;Brachytherapy;2024-05

5. Prostate Cancer;Tata Memorial Centre Textbook of Oncology;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3